Patient Reported Outcome Study on Long Term LoFric Users

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

A prospective, observational cohort study evaluating Patient Reported Outcome in subjects with a long term experience from intermittent catheterization using the LoFric catheter. Prescription and use of LoFric catheters fall within current practice and is not dictated within this Non-Interventional Study.

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05785858` - FLUME Catheter Comfort Study
Recruiting	`NCT05885958` - Timing of Active Void Trials After Urogynecologic Procedures	N/A
Terminated	`NCT05651217` - Clinical Study on Disposable Sterile Urinary Catheter	N/A
Completed	`NCT03289117` - Evaluation of a Novel Medical Device to Facilitate Gel Instillation During Change of Long-term Urinary Catheters	N/A

NCT number	NCT05359198
Study type	Observational
Source	Wellspect HealthCare
Contact
Status	Active, not recruiting
Phase
Start date	June 1, 2015
Completion date	October 8, 2024

Patient Reported Outcome Study on Long Term LoFric Users

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms